- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.01. | GARDP, Debiopharm Partner to Develop Novel Gonorrhea Drug | ||
| 13.01. | Bayer Acquires Attralus Radiotracers, Expands into Molecular Imaging | ||
| 13.01. | AbbVie, RemeGen Partner on Novel Bispecific Antibody for Advanced Tumors | ||
| 13.01. | Kincell Bio Updates Leadership Team | ||
| 13.01. | BD to Invest $110M to Expand Production of Prefillable Syringes | ||
| 13.01. | Tjoapack Expands Bottle Packaging Capabilities at Netherlands Facility | ||
| 13.01. | Piramal Pharma Achieves Improved Score on Global Corporate Sustainability Assessment | ||
| 13.01. | Minaris, Genetix Expand Manufacturing Partnership to Increase Production of LYFGENIA | ||
| 13.01. | Jubilant Biosys Opens New Facility in Noida, India | ||
| 13.01. | Amphastar, Hanxin Enter Exclusive License Agreement for AMP-110 | ||
| 12.01. | LIB Therapeutics' LEROCHOL Receives FDA Approval | ||
| 12.01. | Johnson & Johnson Latest to Reach Drug Price Deal with Trump White House | ||
| 12.01. | Aragen Launches CHOMax Platform to Accelerate Path from DNA to Clinical Supply | ||
| 09.01. | Pierre Fabre, Iktos Enter AI-Driven Drug Discovery Alliance | ||
| 09.01. | Codexis and Axolabs Partner to Advance Enzymatic RNA Manufacturing | ||
| 09.01. | Schreiner MediPharm Expands Needle-Trap Portfolio | ||
| 09.01. | Psilera Appoints Magali Haas Chief Medical Officer | ||
| 09.01. | Halozyme Partners with Takeda to Develop and Commercialize Vedolizumab | ||
| 09.01. | Veeva, BioMarin Enter Long-Term Strategic Partnership | ||
| 09.01. | AstraZeneca Taps Rick Suarez as US President & Head of the US Biopharmaceuticals Business Unit | ||
| 07.01. | Daiichi and GENESIS Will Commercialize VANFLYTA in Parts of Europe | ||
| 07.01. | Viking Therapeutics Hires Neil Aubuchon as Chief Commercial Officer | ||
| 07.01. | Eramol Nears Completion of New Sterile Manufacturing Facility at Sevenoaks | ||
| 07.01. | Qureight Promotes Dr. Steven Bishop to Chief Medical Officer | ||
| 07.01. | Ascidian Therapeutics, Forge Biologics Partner to Advance Stargardt Treatment |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.